Trade Mark Journal No.2026/013 27 March 2026

UK00004355280 16 March 2026 (42,44)

NEOSELECT

International priority date claimed: 10 October 2025 (United States of America) (99436178)

Class 42: Medical and scientific research and analysis in the fields of genetics, oncology, immunology and proteomics; Providing medical and scientific research information in the fields of genetics, oncology, immunology and proteomics; Providing online non-downloadable software for use in analyzing human tissues, cells and proteins; Providing online nondownloadable software for use in immunology and the development of therapeutics for treating cancer and infectious diseases; genetic testing for scientific research and analysis purposes in the fields of oncology, immunology, and development of therapeutics for treating cancer and infectious diseases.
Class 44: Genetic testing for medical purposes; genetic counseling; Medical testing and analysis services for diagnostic and treatment purposes.

Natera, Inc.

Representative: J A Kemp LLP